Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
600381 Qinghai Spring Medicinal Resources Technology
- 3.61
- +0.17+4.94%
Market Closed Dec 20 15:00 CST
2.12BMarket Cap-7.35P/E (TTM)
3.61High3.43Low140.90KlotVolume3.45Open3.44Pre Close50.01MTurnover2.40%Turnover RatioLossP/E (Static)587.06MShares8.2852wk High1.86P/B2.12BFloat Cap1.8452wk Low3.61Limit Up587.06MShs Float50.09Historical High3.27Limit Down5.23%Amplitude0.53Historical Low--Dividend TTM3.55Avg Price52.77KlotAsk--Div YieldTTM100Lot Size85.15KlotBid
Qinghai Spring Medicinal Resources Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 23.22%198.03M | 28.82%138.38M | 49.96%84.5M | 33.52%213.88M | 24.93%160.71M | 1.93%107.42M | -25.09%56.35M | 25.37%160.18M | 57.90%128.65M | 124.00%105.39M |
| Operating revenue | 23.22%198.03M | 28.82%138.38M | 49.96%84.5M | 33.52%213.88M | 24.93%160.71M | 1.93%107.42M | -25.09%56.35M | 25.37%160.18M | 57.90%128.65M | 124.00%105.39M |
| Other operating revenue | ---- | -31.45%2.88M | ---- | 38.18%7.09M | ---- | 60.56%4.2M | ---- | 32.34%5.13M | ---- | 59.42%2.62M |
| Total operating cost | 25.01%284.07M | 23.78%195.16M | 28.95%108.53M | 11.09%322.08M | 14.10%227.23M | 6.00%157.67M | -15.74%84.16M | 23.85%289.92M | 60.99%199.16M | 91.51%148.75M |
| Operating cost | 114.92%116.87M | 103.38%77.06M | 97.33%38.65M | -3.89%82.96M | 5.95%54.38M | -10.46%37.89M | -42.48%19.59M | -15.83%86.32M | 10.45%51.33M | 62.55%42.31M |
| Operating tax surcharges | 18.93%3.49M | -1.80%2.06M | 32.83%989.7K | 12.30%3.7M | 15.59%2.93M | 65.47%2.1M | 1.84%745.07K | -0.74%3.3M | -1.58%2.54M | -32.08%1.27M |
| Operating expense | -11.93%112.19M | -6.42%83.51M | 8.39%54.08M | 38.78%171.03M | 43.57%127.39M | 29.23%89.24M | 3.35%49.9M | 121.34%123.24M | 243.24%88.73M | 277.14%69.06M |
| Administration expense | 17.31%41.12M | 1.17%25.43M | 11.76%13.58M | -18.66%53M | -27.75%35.05M | -23.26%25.14M | -21.83%12.15M | 1.18%65.17M | 12.28%48.52M | 19.95%32.75M |
| Financial expense | 42.99%-42.71K | 11.82%63.8K | 114.92%37.53K | -150.41%-259.29K | -110.83%-74.9K | -85.06%57.06K | -96.38%-251.51K | 136.38%514.4K | 147.01%691.6K | 315.99%381.91K |
| -Interest expense (Financial expense) | -11.71%572.42K | 24.21%570.71K | -13.84%212.84K | 897.01%913.17K | 1,749.96%648.37K | 1,603.18%459.48K | 1,931.57%247.03K | 75.68%91.59K | --35.05K | --26.98K |
| -Interest Income (Financial expense) | 27.43%-725.18K | 19.33%-579.97K | 9.62%-365.67K | -172.54%-1.36M | -174.42%-999.34K | -245.84%-718.97K | -581.33%-404.58K | -186.18%-497.59K | -196.48%-364.17K | -122.63%-207.89K |
| Research and development | 38.16%10.44M | 116.50%7.04M | -41.50%1.19M | 2.30%11.64M | 2.69%7.55M | 9.21%3.25M | 43.80%2.04M | 19.29%11.38M | 4.11%7.36M | -26.83%2.98M |
| Credit Impairment Loss | -32.65%1.8M | -32.55%1.81M | ---- | 63.28%-9.98M | 139.05%2.68M | 139.05%2.68M | ---- | 48.46%-27.18M | 30.48%-6.86M | 30.30%-6.86M |
| Asset Impairment Loss | --108.07K | ---- | ---- | 98.23%-1.64M | ---- | ---- | ---- | -112.34%-92.84M | ---- | ---- |
| Other net revenue | 30.16%4.43M | 31.57%4.19M | -33.56%241.68K | 9.06%-150.78M | 160.06%3.4M | 149.87%3.18M | -62.58%363.77K | -13.42%-165.81M | 68.48%-5.66M | 66.95%-6.38M |
| Fair value change income | 269.16%35.6K | 334.03%28.57K | 980.81%35K | -8.89%-23.06M | 9.30%9.64K | 6.56%6.58K | -0.62%3.24K | 15.71%-21.18M | -11.32%8.82K | -8.83%6.18K |
| Invest income | 322.09%130.13K | 322.09%130.13K | -20.80%58.64K | -352.91%-116.74M | -88.78%30.83K | 117.84%30.83K | -87.95%74.03K | 0.85%-25.78M | 102.98%274.69K | 98.30%-172.78K |
| -Including: Investment income associates | ---- | 98.16%-2.15K | ---- | -461.96%-116.89M | ---- | 88.74%-116.86K | ---- | 31.15%-20.8M | ---- | 91.65%-1.04M |
| Asset deal income | ---- | ---- | ---- | -90.91%1.58K | ---- | ---- | ---- | --17.38K | --17.38K | ---- |
| Other revenue | 243.58%2.35M | 373.56%2.23M | -48.33%148.05K | -43.75%652.02K | -23.16%684.19K | -26.27%469.9K | -19.15%286.5K | -17.23%1.16M | -18.52%890.45K | -3.41%637.32K |
| Operating profit | -29.29%-81.61M | -11.75%-52.59M | 13.34%-23.79M | 12.37%-258.98M | 17.14%-63.12M | 5.40%-47.06M | -15.85%-27.45M | -17.04%-295.55M | -26.54%-76.18M | 0.39%-49.75M |
| Add:Non operating Income | -63.90%17.95K | 90.34%17.95K | 797.72%17.95K | -81.90%61.86K | -85.45%49.73K | -97.24%9.43K | -99.34%2K | 192.35%341.86K | 12,496.67%341.74K | 692,936.40%341.74K |
| Less:Non operating expense | 140.44%3.36M | 1,364.38%2.06M | -59.80%17.25K | 2,121.22%1.36M | 2,720.38%1.4M | 8,024.99%140.73K | 42,979.48%42.92K | 5.69%61.29K | 820.85%49.56K | --1.73K |
| Total profit | -31.77%-84.95M | -15.77%-54.63M | 13.48%-23.79M | 11.85%-260.28M | 15.05%-64.47M | 4.48%-47.19M | -17.54%-27.49M | -16.96%-295.27M | -26.05%-75.89M | 1.07%-49.41M |
| Less:Income tax cost | -10.04%3.7M | 77.62%3.34M | 534.32%2.17M | 176.86%5.93M | 951.18%4.11M | 502.14%1.88M | 92.88%342.85K | -100.68%-7.72M | -139.85%-482.75K | -102.99%-467.37K |
| Net profit | -29.27%-88.65M | -18.13%-57.97M | 6.73%-25.96M | 7.42%-266.21M | 9.05%-68.58M | -0.27%-49.07M | -18.10%-27.84M | -15.66%-287.55M | -25.67%-75.4M | 1.56%-48.94M |
| Net profit from continuing operation | -29.27%-88.65M | -18.13%-57.97M | 6.73%-25.96M | 7.42%-266.21M | 9.05%-68.58M | -0.27%-49.07M | -18.10%-27.84M | -15.66%-287.55M | -25.67%-75.4M | 1.56%-48.94M |
| Less:Minority Profit | 2.79%1.8M | 25.05%1.9M | 6.75%942.61K | 118,393.89%1.65M | --1.75M | --1.52M | --883.03K | ---1.4K | ---- | ---- |
| Net profit of parent company owners | -28.61%-90.45M | -18.34%-59.87M | 6.31%-26.91M | 6.85%-267.87M | 6.73%-70.33M | -3.38%-50.59M | -21.85%-28.72M | -15.66%-287.55M | -25.67%-75.4M | 1.56%-48.94M |
| Earning per share | ||||||||||
| Basic earning per share | -29.17%-0.155 | -18.60%-0.102 | 6.34%-0.0458 | 6.12%-0.46 | 6.25%-0.12 | -3.61%-0.086 | -21.95%-0.0489 | -16.67%-0.49 | -25.49%-0.128 | 2.35%-0.083 |
| Diluted earning per share | -29.17%-0.155 | -18.60%-0.102 | 6.34%-0.0458 | 6.12%-0.46 | 6.25%-0.12 | -3.61%-0.086 | -21.95%-0.0489 | -16.67%-0.49 | -25.49%-0.128 | 2.35%-0.083 |
| Other composite income | ||||||||||
| Total composite income | -29.27%-88.65M | -18.13%-57.97M | 6.73%-25.96M | 7.42%-266.21M | 9.05%-68.58M | -0.27%-49.07M | -18.10%-27.84M | -15.66%-287.55M | -25.67%-75.4M | 1.56%-48.94M |
| Total composite income of parent company owners | -28.61%-90.45M | -18.34%-59.87M | 6.31%-26.91M | 6.85%-267.87M | 6.73%-70.33M | -3.38%-50.59M | -21.85%-28.72M | -15.66%-287.55M | -25.67%-75.4M | 1.56%-48.94M |
| Total composite income of minority owners | 2.79%1.8M | 25.05%1.9M | 6.75%942.61K | 118,393.89%1.65M | --1.75M | --1.52M | --883.03K | ---1.4K | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
